Cell & Gene: The Podcast

Active· last episode 15 days ago

Rate this show

~25 min episodes

About Cell & Gene: The Podcast

Cell & Gene, the most valuable online resource for delivering in-depth content from authoritative authors and sources to professionals in the CGT sector, introduces Cell & Gene: The Podcast. In each episode, Cell & Gene Chief Editor, Erin Harris, will talk to industry and academic leaders about their current initiatives and how they are moving the sector forward.

Language: English
Type: podcast

Episodes(50)

1
How Precision Oncology Is Redefining Cancer Drug Development with Aprea Therapeutics' Dr. Oren Gilad
24 Jul18m
2
Exploring Dendritic Cell Therapy for Solid Tumors with Diakonos Oncology's Jay Hartenbach
24 Jul23m
3
Cell & Gene: The Podcast Presents: Better Biopharma’s Editors’ Roundtable — A Midyear Look at the 2026 Life Sciences Industry
24 Jul1h 26m
4
Why In Vivo Therapies Are Moving Toward the Clinic with Ascidian Therapeutics' Dr. Mike Ehlers
24 Jul18m
5
Reimagining In Vivo Gene Editing Through Base Editing and Targeted Delivery with Beam Therapeutics' Gopi Shanker, Ph.D.
5 Jun18m
6
Advancing CAR T for Drug-Free Remission in Autoimmune Disease with Kyverna Therapeutics’ Dr. Naji Gehchan
4 Jun23m
7
The Future of In Vivo Gene Editing and Clinical Translation with Precision Biosciences' Cassie Gorsuch, Ph.D.
29 May32m
8
Redefining CAR-T Timing and Patient Access with Allogene Therapeutics' Dr. Zachary Roberts
21 May18m

+42 more — listen on the platforms above

Listener comments

Join the conversation. Members can leave comments and discover other listeners.

About Cell & Gene: The Podcast

Language: English
Type: podcast

Episodes(50)

How Precision Oncology Is Redefining Cancer Drug Development with Aprea Therapeutics' Dr. Oren Gilad

24 Jul18m

Exploring Dendritic Cell Therapy for Solid Tumors with Diakonos Oncology's Jay Hartenbach

24 Jul23m

Cell & Gene: The Podcast Presents: Better Biopharma’s Editors’ Roundtable — A Midyear Look at the 2026 Life Sciences Industry

24 Jul1h 26m

Why In Vivo Therapies Are Moving Toward the Clinic with Ascidian Therapeutics' Dr. Mike Ehlers

24 Jul18m

Reimagining In Vivo Gene Editing Through Base Editing and Targeted Delivery with Beam Therapeutics' Gopi Shanker, Ph.D.

5 Jun18m

Advancing CAR T for Drug-Free Remission in Autoimmune Disease with Kyverna Therapeutics’ Dr. Naji Gehchan

4 Jun23m

The Future of In Vivo Gene Editing and Clinical Translation with Precision Biosciences' Cassie Gorsuch, Ph.D.

29 May32m

Redefining CAR-T Timing and Patient Access with Allogene Therapeutics' Dr. Zachary Roberts

21 May18m

+42 more — listen on the platforms above